You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020121012
Dec 20201905
Jan 20212203
Feb 20211806
Mar 20214206
Apr 20211602
May 2021304
Jun 2021003
Jul 2021005
Aug 2021002
Sep 2021005
Oct 202116015
Nov 202142014
Dec 20211200
Jan 20221800
Feb 20221000
Mar 20222005
Apr 20224203
May 20222001
Jun 20223802
Jul 20222201
Aug 20223006
Sep 20221801
Oct 20222401
Nov 20221400
Dec 20222000
Jan 20231800
Feb 20231401
Mar 20233001
Apr 20231202
May 2023800
Jun 2023400
Jul 20231200
Aug 2023600
Sep 20231000
Oct 20231401
Nov 20232602
Dec 20234000
Jan 20243201
Feb 20241800
Mar 20241401
Apr 20241200
May 20242000
Jun 20243601
Jul 20241801
Aug 2024800
Sep 20241601
Oct 2024804
Nov 20241202
Dec 20241405
Jan 20251409
Feb 2025002
Mar 2025003
Apr 2025003
May 2025002
Jun 2025002
Total10030146